Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Midazolam Injection
Status: Currently in Shortage
»Date first posted:
04/02/2020
»Therapeutic Categories: Anesthesia; Neurology
Akorn Pharmaceuticals (Revised 03/01/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 10 ML Vial - Pack of 10 (NDC 17478-0524-10) | Not available | No new manufacturing of product |
Avet Pharmaceuticals Inc (Revised 10/31/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50 mg/10mL vial (NDC 23155-601-42) | Available | Other | |
| 25 mg/5mL vial (NDC 23155-601-41) | Available | Other | |
| 2 mg/2mL vial (NDC 23155-600-41) | Available; On allocation due to increased demand | Other |
Fresenius Kabi USA, LLC (Revised 03/10/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 2 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10) | 3 month expiry (6/30/2023 expiry) dating available by request. | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02) | Available | Check wholesalers for inventory | Demand increase for the drug |
Gland Pharma Limited (Reverified 03/10/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10) | Available | Demand increase for the drug | |
| 25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05) | Available | Demand increase for the drug | |
| 25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17) | No stock available | Demand increase for the drug | |
| 50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91) | Available | Demand increase for the drug | |
| 2 mg per 2 mL Single Dose Vial (NDC 70860-600-02) | Available | Demand increase for the drug | |
| 2 mg per 2 mL Single Dose Vial (NDC 47781-588-68) | Available | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 08/26/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10) | Available | Demand increase for the drug | |
| 1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25) | Available | Demand increase for the drug | |
| 1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25) | Available | Demand increase for the drug | |
| 5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10) | This presentation is temporarily on backorder. | Demand increase for the drug |
Hospira, Inc., a Pfizer company (Revised 03/17/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/2mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-17) | Next Delivery: March 2023; Estimated Recovery: March 2024 | Demand increase for the drug | |
| 5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-05) | Available | Other | |
| 5 mg/mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-01) | Next Delivery: March 2023; Estimated Recovery: March 2024 |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Demand increase for the drug |
| 50 mg/10 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-05) | Available |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Other |
| 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-02) | Limited Supply Available. Next Delivery: March 2023; Estimated Recovery: December 2023 |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Demand increase for the drug |
| 25 mg/5 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-03) | Available |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Other |
| 10 mg/10 mL (1 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2587-05) | Limited Supply Available. Next Delivery: July 2023; Estimated Recovery: September 2023 | Demand increase for the drug |
WG Critical Care (Reverified 10/03/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50mg/50mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag (NDC 44567-610-10) | Available | ||
| 100mg/100mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag (NDC 44567-611-10) | Available |